Genmab — December 2020
-
-
Konsensus blandt onkologer er at det er rigtig godt
-
it does look really good, safety also https://twitter.com/lymphomahub/status/1335686290805837828/photo/4
-
Better than the comparison nos we saw on Friday
-
Hutchings glofitamab præsentation https://twitter.com/graham74gc/status/1335689743347179527?s=21
-
epcos safety bedre
-
mange grade 3-4 AEs hos glofitamab
-
Begge Roche cd3/cd20 bsabs har grade 3-4 AEs. Safety må klart være til epcos fordel
-
det ser så fint ud med Epco. Helt utrolig track record Genmab har.
-
J&J try to steel og find out what had happend!http://o-d-i-n.net/slagt-guldkalven-kraemmersjaelenes-alter/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind